At the Medical Product Advertising Customer Council at Emirates Towers, the Emirates Drug Establishment (EDE) outlined regulatory updates for promotional content across conventional and digital channels. The meeting brought together partners, customers and industry representatives and stressed the need to secure approval before medical advertising is released.

Among the issues explored was advertising for Prescription-Only Medicines (POMs) under approved regulatory controls. The council considered advertising through print, audio and visual material, including outdoor screens, as well as websites, social media platforms and other digital channels.

Participants reviewed the advertisement licensing system, including how to submit applications, the supporting documents and advertising content required for different product types and media channels, and the review process. Discussions also covered the requirements for completing applications.

The EDE emphasized that promotional claims must be accurate, clear and free of misleading information. Advertising material must match a product's approved information and uses, while relevant risks or side effects must be disclosed clearly.

The council also considered disclaimers required according to the product category and intended audience. Advertisements must not encourage members of the public to self-diagnose or self-prescribe without appropriate supervision by a healthcare professional.

The regulator reiterated that advertising, promoting or endorsing medical products through social media influencers is prohibited. It also discussed inspection and control mechanisms across media channels, including coordination with relevant authorities to act against and remove non-compliant material when necessary.

Customers used the meeting to raise inquiries and share feedback on the service and the practical aspects of submitting applications. The discussions considered ways to clarify procedures and help applicants meet submission requirements as part of the EDE's efforts to improve its services, support compliant advertising and promote the safe use of medical products.